Literature DB >> 7961799

Surfactant properties of Alzheimer's A beta peptides and the mechanism of amyloid aggregation.

B Soreghan1, J Kosmoski, C Glabe.   

Abstract

The major proteinaceous component of amyloid deposits associated with Alzheimer's disease is a self-assembling 40-42-residue peptide, known as A beta, which is generated by the proteolytic processing of the amyloid precursor protein (Kang, J., Lemaire, H. G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K. H., Multhaup, G., Beyreuther, K., and Muller-Hill, B. (1987) Nature 325, 733-736; Haass, C., Hung, A. Y., Schlossmacher, M. G., Oltersdorf, T., Teplow, D. B., and Selkoe, D. J. (1993) Ann. N. Y. Acad. Sci. 695, 109-116; Estus, S., Golde, T. E., and Younkin S. G. (1992) Ann. N. Y. Acad. Sci. 674, 138-148) and is implicated as one of the causal factors in the pathology of the disease. A beta is now shown to display properties commonly associated with surfactants or detergents, which form micelles in solution. Increasing concentrations of A beta lower the surface tension of water up to a critical concentration, above which little further decrease in surface tension is observed. At concentrations above this critical concentration, increasing amounts of non-covalent aggregates of A beta are observed. A beta aggregation is also correlated with the formation of a hydrophobic environment that excludes water. The extent of this hydrophobic environment, as reflected by the partitioning of hydrophobic fluorescent probes, is much higher for the longer A beta 1-42 isoform, which may be more intimately associated with Alzheimer's disease pathology than A beta 1-40. Although the solution structure of A beta is not yet known, these results suggest that the structure of A beta has the same type of axial amphipathic organization as detergent molecules and that the same principles that govern micelle formation may also apply to A beta aggregation and amyloid fibril self-assembly.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7961799

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  65 in total

1.  Charge-based binding of complement component C1q to the Alzheimer amyloid beta-peptide.

Authors:  S Webster; B Bonnell; J Rogers
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

2.  Concentration effect on the aggregation of a self-assembling oligopeptide.

Authors:  S Y Fung; C Keyes; J Duhamel; P Chen
Journal:  Biophys J       Date:  2003-07       Impact factor: 4.033

3.  Molecular dynamics simulation of amyloid beta dimer formation.

Authors:  B Urbanc; L Cruz; F Ding; D Sammond; S Khare; S V Buldyrev; H E Stanley; N V Dokholyan
Journal:  Biophys J       Date:  2004-10       Impact factor: 4.033

4.  Enrichment of amyloidogenesis at an air-water interface.

Authors:  Létitia Jean; Chiu Fan Lee; David J Vaux
Journal:  Biophys J       Date:  2012-03-06       Impact factor: 4.033

5.  Amyloid formation: Interface influence.

Authors:  Ian W Hamley
Journal:  Nat Chem       Date:  2010-09       Impact factor: 24.427

6.  Amyloid-beta fibrillogenesis seeded by interface-induced peptide misfolding and self-assembly.

Authors:  Eva Y Chi; Shelli L Frey; Amy Winans; Kin Lok H Lam; Kristian Kjaer; Jaroslaw Majewski; Ka Yee C Lee
Journal:  Biophys J       Date:  2010-05-19       Impact factor: 4.033

7.  Molecular dynamics simulations of spontaneous fibril formation by random-coil peptides.

Authors:  Hung D Nguyen; Carol K Hall
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-08       Impact factor: 11.205

8.  Impact of the mutation A21G (Flemish variant) on Alzheimer's beta-amyloid dimers by molecular dynamics simulations.

Authors:  Alexis Huet; Philippe Derreumaux
Journal:  Biophys J       Date:  2006-08-04       Impact factor: 4.033

Review 9.  Amyloid beta: structure, biology and structure-based therapeutic development.

Authors:  Guo-Fang Chen; Ting-Hai Xu; Yan Yan; Yu-Ren Zhou; Yi Jiang; Karsten Melcher; H Eric Xu
Journal:  Acta Pharmacol Sin       Date:  2017-07-17       Impact factor: 6.150

10.  Alzheimer's disease protein Abeta1-42 does not disrupt isolated synaptic vesicles.

Authors:  Peter B Allen; Daniel T Chiu
Journal:  Biochim Biophys Acta       Date:  2008-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.